Comparative data on quality of care and outcome are urgently neededBMJ 1995; 310 doi: http://dx.doi.org/10.1136/bmj.310.6983.874b (Published 01 April 1995) Cite this as: BMJ 1995;310:874
- Maggie Harding
- Senior registrar in public health medicine Health Care Evaluation Unit, Department of Public Health Sciences, St George's Hospital Medical School, London SW17 0RE
EDITOR,—Bone marrow transplantation has a high profile in health care. Restricted access was the catalyst for the priority setting exercise in Oregon, and there is controversy about American insurers' liability to cover new technology of unproved benefit. Richard L Soutar and Derek J King's review of bone marrow transplantation1—or, in recognition of alternative sources of stem cells,1 2 transplantation of haemopoietic stem cells—is educational; debate on important issues of access, appropriateness, and quality of care continues.
Access to transplantation of allogeneic haemopoietic stem cells varies …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial